Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bio-Techne Corp TECH

Healthcare  —  Biotechnology
72.61 0.04 0.06% as of 25 Sep
Market cap
$11.4B
P/E
62.1×
S&P 500 Member Dividend Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bio-Techne Corp (TECH) Return on invested capital

Bio-Techne Corp's return on invested capital over the twelve months to 30 June 2026 was 7.70%. Over the past ten years it has ranged from 3.04% (fiscal 2025) to 11.4% (fiscal 2015); the current reading is higher than 58% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.

Return on invested capital, annual

Annual

Period Return on invested capital Change (points)
FY2026 7.70% 4.66
FY2025 3.04% (2.74)
FY2024 5.78% (3.02)
FY2023 8.80% (2.04)
FY2022 10.8% 2.02
FY2021 8.82% 2.11
FY2020 6.71% 0.62
FY2019 6.09% (0.79)
FY2018 6.88% 0.24
FY2017 6.64% (4.07)

Against its own ten years

Low 3.04% High 11.4%
Ten-year median 7.29%
Current reading's percentile 58

Return on invested capital against peers

Company Return on invested capital
KRYS Krystal Biotech, Inc. compare 24.1%
HALO Halozyme Therapeutics, Inc. compare 18.1%
TECH Bio-Techne Corp 7.70%
CORT Corcept Therapeutics Incorporated compare 1.01%
BMRN BioMarin Pharmaceutical Inc. compare 0.97%
AXSM Axsome Therapeutics, Inc. compare 0.00%
SMMT Summit Therapeutics PLC compare 0.00%
BBIO BridgeBio Pharma, Inc. compare 0.00%
MDGL Madrigal Pharmaceuticals, Inc. compare −787.3%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Return on invested capital is

Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.

TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)

The full definition of Return on invested capital →

More on TECH